Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04902924
Other study ID # 2021-00546
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2021
Est. completion date May 1, 2022

Study information

Verified date April 2024
Source University of Applied Sciences and Arts of Southern Switzerland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall aim of this study is, to evaluate the effectiveness of repeated cold- and warm water immersion on performance recovery after muscle damage.


Description:

Participants perform a muscle-damage protocol, which comprises 5x20 drop jumps. After the exercise protocol is finished, the participants will undergo one of three recovery interventions. Cold-water immersion, Warm-water immersion or the control-intervention. During the exercise protocol and the recovery intervention following parameters will be assessed: Blood oxygenation, Muscle oxygenation, heart-rate, skin temperature and core temperature. Then, performance recovery will be assessed during the following 72 hrs (in a 24 hrs interval). At each time-point, following measurements will be conducted: vertical-jump performance, maximum voluntary isometric contraction of the m.quadriceps femoris muscle, muscle swelling and delayed-onset of muscle soreness.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date May 1, 2022
Est. primary completion date April 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Healthy participants - No surgeries - No previous injuries - Anticonceptiva allowed Exclusion Criteria: - Acute injuries or current pain situations - Cryophobia - Fear - Pregnancy - Raynaud syndrome - Medication intake

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
repeated cold water therapy
This information can be found the description of the experimental arm.
repeated warm water therapy
This information can be found the description of the experimental arm.
Other:
control
This information can be found the description of the experimental arm.

Locations

Country Name City State
Switzerland University of Applied Sciences and Arts of Southern Switzerland Landquart GR

Sponsors (1)

Lead Sponsor Collaborator
University of Applied Sciences and Arts of Southern Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary maximun voluntary isometric contraction (Nm) maximun voluntary isometric contraction of the knee extensor muscle will be assessed. baseline to 72 hours
Primary vertical jump performance (cm) maximum vertical jump performance will be measured baseline to 72 hours
Primary delayed onset of muscle soreness (units) delayed onset of muscle soreness will be measured using a 0-10 scale, where 0 indicated no soreness and 10 indicates maximum soreness of the knee extensor muscles baseline to 72 hours
Primary muscle swelling (mm) swelling of the knee extensor muscle will be performed using a ultrasound device. baseline to 72 hours
Primary Creatine-kinase (U/l) using a blood sample (6 ml), creatine-kinase will be assessed baseline to 72 hours
Primary blood oxygenation (%) Blood oxygenation will be measured using near-infrared spectroscopy device at the finger through recovery intervention up to 1 hour
Primary muscle blood oxygenation (%) Muscle oxygenation will be measured using near-infrared spectroscopy device at the knee extensor muscle through recovery intervention up to 1 hour
Primary skin temperature (°C) Skin temperature will be measured using a near infrared thermography camera through recovery intervention up to 1 hour
Primary core temperature (°C) core temperature will be measured using temperature pill that will provide real time values from the gastrointestinal region through recovery intervention up to 1 hour
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1